Syndromes Without a Name Bring Labs an Uphill Battle
In an era when genetic and genomic testing are theoretically affordable and accessible, why do so many patients remain undiagnosed?
In an era when genetic and genomic testing are theoretically affordable and accessible, why do so many patients remain undiagnosed?
From - Diagnostic Testing & Emerging Technologies
The US Preventive Services Task Force (USPSTF) issued updated recommendations for BRCA-related cancer risk assessment…
From - Diagnostic Testing & Emerging Technologies
The clinical value of performing multigene panel for inherited cancer in patients with metastatic breast cancer has…
From - Diagnostic Testing & Emerging Technologies
Developing a cost-effective blood test capable of accurately detecting early Alzheimer's disease that can be…
From - Diagnostic Testing & Emerging Technologies
The T2Bacteria Panel (T2Biosystems; Lexington, Mass.) can rapidly and accurately diagnoses bloodstream infections (BSIs) caused by…
From - Diagnostic Testing & Emerging Technologies
The neutrophil-lymphocyte ratio (NLR) may be a marker to aid in diagnosing erectile dysfunction (ED), according to…